Zogenix, Battelle agree to work toward out-licensing needle-free injection platform
26 January 2012
Nancy Faigen
Please Login to read the full article.
26 January 2012
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zogenix's long-acting hydrocodone meets chronic pain endpoint, ready for 2012 filing
- Zogenix plans offering of 12M shares, as it moves forward on chronic pain product
- Zogenix expects little fall-out from end of Astellas tie-up for Sumavel
- Zogenix, Duract in deal for work on once-monthly risperidone, to contrast with J&J blockbuster
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
